PHARMACOECONOMIC ANALYSIS OF THE THERAPY OF СHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS IN HOSPITAL CONDITIONS

PHARMACOECONOMIC ANALYSIS OF THE THERAPY OF СHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS IN HOSPITAL CONDITIONS

Objective. To determine the priority used to vital drugs in сhronic obstructive pulmonary disease (COPD) patients in hospitals of the Kirov region.Materials and Methods. We analyzed 143 medical records of the patient, the analysis of cost of illness, ABC\ VEN — analysis.Results. The results of АВС a...

Full description

Bibliographic Details
Main Authors:	E. E. Vidyakina, S. V. Malchikova
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2016-09-01
Series:	Фармакоэкономика
Subjects:	chronic obstructive pulmonary disease copd pharmacoeconomics cost авс ven baseline therapy inpatient department
Online Access:	https://www.pharmacoeconomics.ru/jour/article/view/147

Similar Items

STUDY OF TYPICAL PRACTICE OF MANAGEMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AT THE STATIONARY STAGE
by: E. E. VIDYAKINA, et al.
Published: (2016-12-01)

PHARMACO-ECONOMIC ANALYSIS OF COST IN TERMS OF MAINTENANCE OF PREFERENTIAL MEDICINES PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON THE TERRITORY OF KRASNOYARSK REGION
by: T. V. Gaygolnik, et al.
Published: (2016-09-01)

INFLUENCE OF HEALTH SCHOOL TRAINING OF PATIENTS WITH ISCHEMIC HEART DISEASE ON PHARMACOTHERAPY PROFILE AND COST (АВС/VEN ANALYSIS)
by: A. V. Kontsevaja, et al.
Published: (2016-01-01)

Pharmacoeconomic features of drug provision to the rheumatology department of the republican clinical hospital
by: L. N. Sheikhmambetova, et al.
Published: (2021-10-01)

Pharmacoeconomic evaluation of drug supply for chemotherapy in small cell lung cancer
by: Yelena A. Lunyova
Published: (2023-07-01)

Pharmacoeconomics of Bronchial Asthma
by: Ivanova Zlatina I., et al.
Published: (2019-06-01)

Pharmacoeconomic analysis in various nosologies
by: A. A. Svistunov, et al.
Published: (2022-12-01)

PHARMACOECONOMIC STUDY OVER USE OF ANTICHOLINERGIC BRONCHODILATORS (SPIRIVA AND ATROVENT) FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: A. U. Kulikov, et al.
Published: (2015-03-01)

Meta-analysis of the impact of eosinophilia and its baseline characteristics on the exacerbation of chronic obstructive pulmonary disease
by: Lan-miao Li, et al.
Published: (2023-05-01)

Development conceptual of pharmacoeconomic model of technology for early diagnosis and pharmacotherapy of pulmonary arterial hypertension
by: I. S. Datsenko
Published: (2022-12-01)

Scientific substantiation of the concept of pharmacoeconomic analysis of technologies for early diagnosis and pharmacotherapy of pulmonary arterial hypertension
by: I. S. Datsenko, et al.
Published: (2022-10-01)

Pharmacoeconomic particulars of ovaries cancer’s treatment
by: V N Zhurman, et al.
Published: (2015-06-01)

PHARMACOECONOMICS OF APPLICATION OF HEPATOPROTECTORS IN THERAPY OF DRUG-INDUCED LIVER INJURY AFTER CHEMOTHERAPY
by: D. D. Morikov, et al.
Published: (2017-04-01)

Is it possible to reverse frailty in patients with chronic obstructive pulmonary disease?
by: Zhe Wang, et al.
Published: (2020-10-01)

Outlook of Pharmacoeconomics and its status in Nepal
by: Sabita Paudel
Published: (2018-03-01)

PHARMACOECONOMIC STUDY OF OLMESARTAN/LERCANIDIPINE AND OFENOPRIL/LERCANIDIPINE COMBINATIONS IN THE TREATMENT OF PATIENTS WITH ESSENTIAL HYPERTENSION
by: D. S. Kaskaeva, et al.
Published: (2017-03-01)

Trends in Hospital Admissions for Chronic Obstructive Pulmonary Disease in Men and Women in Spain, 1998 to 2018
by: Domingo Orozco-Beltrán, et al.
Published: (2021-04-01)

Is Frailty a Mortality Predictor in Subjects with Chronic Obstructive Pulmonary Disease?
by: Nishimura K, et al.
Published: (2023-12-01)

Healthcare resource utilization in patients with pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD): a real-world data analysis
by: Tracey Weiss, et al.
Published: (2023-11-01)

Digital health in chronic obstructive pulmonary disease
by: Huanyu Long, et al.
Published: (2023-06-01)

Aspergillus infection in chronic obstructive pulmonary diseases
by: Liang Guo, et al.
Published: (2023-03-01)

How Accurate Is the Diagnosis of “Chronic Obstructive Pulmonary Disease” in Patients Hospitalized with an Acute Exacerbation?
by: Fares Darawshy, et al.
Published: (2023-03-01)

Early cardiovascular involvement in Chronic Obstructive Pulmonary Disease
by: M. Malerba, et al.
Published: (2016-01-01)

Editorial: Challenges of Pharmacoeconomics in Global Health Arena
by: Mihajlo Jakovljevic, et al.
Published: (2018-12-01)

Determination of The Factors Affecting Duration of Hospitalization Inpatients With Chronic Obstructive Pulmonary Disease (COPD) in Iran
by: Malihe Naghavi, et al.
Published: (2008-05-01)

Pharmacoeconomic aspects of the use of bronchodilators in the management of COPD: real clinical practice
by: Р. A. Balunov, et al.
Published: (2019-01-01)

Evaluation of three scales of dyspnea in chronic obstructive pulmonary disease
by: Chhabra S, et al.
Published: (2009-01-01)

Adherence to Treatment Recommendations for Chronic Obstructive Pulmonary Disease - Results from the Swedish National Airway Register
by: Larsson K, et al.
Published: (2021-04-01)

Responsiveness of PROMIS® to change in chronic obstructive pulmonary disease
by: Susan E. Yount, et al.
Published: (2019-10-01)

Characteristics of patients referred to Canary Island pneumology outpatient services for chronic obstructive pulmonary disease: the EPOCan study
by: Juan Marco Figueira-Gonçalves, et al.
Published: (2022-02-01)

Mechanisms, Pathophysiology and Currently Proposed Treatments of Chronic Obstructive Pulmonary Disease
by: Sarah de Oliveira Rodrigues, et al.
Published: (2021-09-01)

Viruses and exacerbations of chronic obstructive pulmonary disease: unmet clinical need
by: L. Buss, et al.
Published: (2015-07-01)

Prevalence of chronic obstructive pulmonary disease (COPD) among rheumatoid arthritis: results from national inpatient database
by: Rashmi Dhital, et al.
Published: (2018-07-01)

Vitamin D and chronic obstructive pulmonary disease
by: Azza Farag Said, et al.
Published: (2015-01-01)

Extracellular vesicles and chronic obstructive pulmonary disease (COPD): a systematic review
by: Nancy Gomez, et al.
Published: (2022-04-01)

Comorbidities of Chronic Obstructive Pulmonary Disease Patients at Respirology and Critical Care Outpatient Clinic Dr. Hasan Sadikin General Hospital, Bandung, Indonesia
by: Adrian Sebastian Suhendro, et al.
Published: (2017-03-01)

Pharmacoeconomic justification of the choice of specific therapy schemes for the treatment of adult patients with pulmonary arterial hypertension
by: I. S. Datsenko, et al.
Published: (2022-08-01)

The relationship between air pollution exposure and chronic obstructive pulmonary disease in Ahvaz, Iran
by: Gholamreza Goudarzi, et al.
Published: (2015-01-01)

Nursing Outcomes and Risk Factors of Patients with Chronic Obstructive Pulmonary Disease After Discharge
by: Chai YH, et al.
Published: (2021-10-01)

The importance of the relationship between chronic periodontitis and chronic obstructive pulmonary disease
by: Tamás Tián, et al.
Published: (2021-03-01)